Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models

Konstantin N. Zabegalov, Tatiana O. Kolesnikova, Sergey L. Khatsko, Andrey D. Volgin, Oleg A. Yakovlev, Tamara G. Amstislavskaya, Polina A. Alekseeva, Darya A. Meshalkina, Ashton J. Friend, Wandong Bao, Konstantin A. Demin, Raul R. Gainetdinov, Allan V. Kalueff

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)129-140
Number of pages12
JournalEuropean Journal of Pharmacology
Volume829
DOIs
Publication statusPublished - 15 Jun 2018

Keywords

  • Animal models
  • Antidepressants
  • Depression
  • Discontinuation syndrome
  • Side effects

ASJC Scopus subject areas

  • Pharmacology

WoS ResearchAreas Categories

  • Pharmacology & Pharmacy

Fingerprint

Dive into the research topics of 'Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models'. Together they form a unique fingerprint.

Cite this